Assess whether pediatric studies are necessary or waivable (91d1a6)

Situation

The desk packet is scientific-advice briefing book after an FAERS cluster in a demographic the trials under-enrolled. Clinical-development physician in a 505(b)(2) program relying on literature plus a bridging study has to name Pediatric studies are necessary or Waivable for this Pharma & Life Sciences Pharmacovigilance file.

Decision

Clinical-development physician in a 505(b)(2) program relying on literature plus a bridging study must choose Pediatric studies are necessary / Waivable using scientific-advice briefing book after an FAERS cluster in a demographic the trials under-enrolled.

Hypotheses to test

• Scientific-advice briefing book reads as Pediatric studies are necessary once an FAERS cluster in a demographic the trials under-enrolled is lined up to the same Pharma & Life Sciences population.
• Scientific-advice briefing book is closer to Waivable after an FAERS cluster in a demographic the trials under-enrolled; Pediatric studies are necessary would over-claim this Pharmacovigilance extract.
• A dual reading is still live in scientific-advice briefing book for clinical-development physician in a 505(b)(2) program relying on literature plus a bridging study.
• Scientific-advice briefing book is missing the fact clinical-development physician needs after an FAERS cluster in a demographic the trials under-enrolled; stop this Pharma & Life Sciences close.

Analysis required

• Separate an isolated adverse event from a systemic quality issue.
• Test a protocol deviation versus a safety signal versus a filing gap on pediatric studies are necessary.
• Check whether scientific-advice briefing book supports the labeled claim clinical-development physician would keep.
• For this Pharma & Life Sciences Pharmacovigilance file, read scientific-advice briefing book against an FAERS cluster in a demographic the trials under-enrolled and write the one fact that would move pediatric studies are necessary for clinical-development physician.

Recommendation

Choose Pediatric studies are necessary / Waivable on this Pharma & Life Sciences / Pharmacovigilance packet (scientific-advice briefing book after an FAERS cluster in a demographic the trials under-enrolled). Lead with the Pharma & Life Sciences option scientific-advice briefing book can support after an FAERS cluster in a demographic the trials under-enrolled, then the two facts that force it, then the Monday action for clinical-development physician in a 505(b)(2) program relying on literature plus a bridging study.